Cited by 52Congenital heart defects researchHippo pathway signaling and YAP/TAZTissue Engineering and Regenerative Medicine

Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation

Open access
Lin, Zhiqiang, Pu, William T.·2014·Stem Cell Research

Abstract

The adult mammalian heart exhibits limited regenerative capacity after myocardial injury, a shortcoming that is responsible for the current lack of definitive treatments for heart failure. A search for approaches that might enhance adult heart regeneration has led to interest in the Hippo/Yap signaling pathway, a recently discovered signaling pathway that regulates cell proliferation and organ growth. Here we provide a brief overview of the Hippo/Yap pathway and its known roles in the developing and adult heart. We discuss the implications of Hippo/Yap signaling for regulation of cardiomyocyte death and regeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.scr.2014.04.010

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Yap loss- or gain-of-function in the embryonic heart is frequently lethal.

    “Several studies show that Yap loss- or gainof-function in the embryonic heart is frequently lethal (reviewed by (84, 141, 155)).”

    From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [84]

    The cardiac hypertrophy and apoptosis section reports that two studies found premature death after late-fetal cardiac Yap inactivation. The heart-development section reports hypoplasia with early YAP loss and overgrowth with YAP gain, but does not say that gain of function was lethal or establish that either manipulation was frequently lethal. The heart-regeneration section notes that some mice with embryonic YAP overexpression survived to adulthood. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 77 · Cited by 52

Authors
Lin, Z., & Pu, W. T.
Affiliations
Boston Children's Hospital (US)
Corresponding author
Pu, William T.
Venue
Stem Cell Research
Publisher
Elsevier BV
Published
2014-11
Volume
13
Issue
3
Pages
571-581
ISSN
1873-5061 (ISSN-L)
OpenAlex
W1967359849
Cited by
52
References
77
Citations by year
2026: 1 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 9 · 2016: 8 · 2015: 4
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Research (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • NIH (HL116461, HL100401)
  • American Heart Association
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
Hippo signaling pathway, YAP, cardiac regeneration, cardiomyocyte death, myocardial injury, heart failure, cardiomyocyte proliferation, heart development, organ growth regulation
MeSH terms
Hippo Signaling Pathway, YAP-Signaling Proteins, Animals, Heart, Heart Diseases, Humans, Phosphoproteins, Regeneration, Rejuvenation, Transcription Factors, Signal Transduction, Protein Serine-Threonine Kinases, Myocytes, Cardiac, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review